HIV medication worldwide sales by type 2008-2012

This statistic depicts the differentiation in worldwide sales for human immunodeficiency virus (HIV) medication from 2008 to 2012, by drug type. In 2010, the fixed-dose combination drugs accounted for 56% and plain active ingredient drugs accounted for 44% of HIV medication sold. In 2013, about 34 million people around the world were suffering from HIV but due to advances in medication, it is considered a manageable chronic condition. Although, antiretroviral therapy has made living with HIV much more manageable, there are many in the developing world that still have no access to sufficient medical treatment. HIV antiviral volume is decreasing as fixed-dose combination therapy becomes more prominent.

Percentage of global HIV medication sales by type from 2008 to 2012

Exclusive Premium statistic

You need a Premium Account for unlimited access.

  • Full access to 1m statistics

  • Incl. source references

  • Available to download in PNG, PDF, XLS format

Premium Account

only $59 / month *
*Duration: 12 months, billed annually, single license

Access to this and all other statistics on 80,000 topics from

$708 / Year

Show detailed source information?
Register for free
Already a member?
Log in
Source

Release date

December 2013

Region

Worldwide

Survey time period

2008 to 2012

Statista Accounts: Access All Statistics. Starting from $708 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.
This statistic is not included in your account!

Premium Account
Your perfect start with Statista
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references

$59 / Month *

Corporate Account
Full access

Corporate solution including all features.

* All products require an annual contract.
   Prices do not include sales tax.

Statistics on "HIV/AIDS in the U.S."

Statista Accounts: Access All Statistics. Starting from $708 / Year
Learn more about how Statista can support your business.